Porcine circovirus 2 (PCV2) is a circular single-stranded DNA virus responsible for a group of diseases collectively known as PCV2 Associated Diseases (PCVAD). Variation in the incidence and severity of PCVAD exists between pigs suggesting a host genetic component involved in pathogenesis. A large-scale genome-wide association study of experimentally infected pigs (n = 974), provided evidence of a host genetic role in PCV2 viremia, immune response and growth during challenge. Host genotype explained 64% of the phenotypic variation for overall viral load, with two major Quantitative Trait Loci (QTL) identified on chromosome 7 (SSC7) near the swine leukocyte antigen complex class II locus and on the proximal end of chromosome 12 (SSC12). The SNP having the strongest association, ALGA0110477 (SSC12), explained 9.3% of the genetic and 6.2% of the phenotypic variance for viral load. Dissection of the SSC12 QTL based on gene annotation, genomic and RNA-sequencing, suggested that a missense mutation in the SYNGR2 (SYNGR2 p.Arg63Cys) gene is potentially responsible for the variation in viremia. This polymorphism, located within a protein domain conserved across mammals, results in an amino acid variant SYNGR2 p.63Cys only observed in swine. PCV2 titer in PK15 cells decreased when the expression of SYNGR2 was silenced by specific-siRNA, indicating a role of SYNGR2 in viral replication. Additionally, a PK15 edited clone generated by CRISPR-Cas9, carrying a partial deletion of the second exon that harbors a key domain and the SYNGR2 p.Arg63Cys, was associated with a lower viral titer compared to wildtype PK15 cells (>24 hpi) and supernatant (>48hpi)(P < 0.05). Identification of a non-conservative substitution in this key domain of SYNGR2 suggests that the SYNGR2 p.Arg63Cys variant may underlie the observed genetic effect on viral load.
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Introduction
Porcine Circovirus 2 (PCV2) is a member of the Circoviridae family and the smallest virus known to infect mammalian cells. Despite its small size, this single-stranded circular DNA virus has been identified as the causative source of a set of systemic disorders known as Porcine Circovirus Associated Diseases (PCVAD), which includes Post-Weaning Multi-systemic Wasting Syndrome (PMWS). PMWS is characterized by severe weight loss, respiratory and enteritic conditions that can lead to mortality [1] . Other symptoms associated with PCVAD include nephritis, dermatitis, reproductive failure, interstitial pneumonia, and lymphoid depletion. PCV2 infection can be detected in all domestic populations of pigs, but most infections are subclinical and only a subset of pigs that experience various triggering factors develop clinical disease [2] . The frequency of subclinical infection, combined with environmental stability of the virus, has enabled PCV2 to spread worldwide and persist undetected for generations. For example, the first documented PMWS outbreak occurred in 1991, but PCV2 was identified in archival semen samples collected in the early 1970s [3] . Current PCV2 isolates display consistent variation in a 9 bp region of the capsid gene, associated with increased virulence in experimental infection of gnotobiotic pigs, compared to archival PCV2 isolates, indicating viral genetic variation associated with virulence [3] .
Anecdotal field data and initial experimental evidence [4, 5] described differences between breeds in both incidence and severity of PCVAD [6] , supporting the role for host genetic variation in the etiology of the disease. In our first genome-wide association study (GWAS), we found that host genetics influenced PCV2 titer and accounted for an important proportion of the phenotypic variation (~45%) for viral load [7] . In this study, we integrated two datasets of pigs experimentally infected with a PCV2b strain [7, 8] and in vitro siRNA and gene editing validation models to elucidate the role of host genetics in pathogenesis by identifying genes and genetic variants that could influence PCV2 susceptibility.
Results

Two genomic loci influence host genetic effect on PCV2 infection
Substantial variation in the timing and magnitude of immune response, and in the efficiency of PCV2 replication, was reported in our previous studies of experimental infection with a PCV2b strain [7, 8] . The present study extends that work by examining the influence of host genetics on the process of infection, based on a combination of the two previous study populations (n = 974 F1 crossbred pigs originating from 14 genetic lines) challenged by experimental infection with PCV2b and genotyped with 56,557 SNPs (Porcine SNP60 BeadArray). The population structure provides substantial variation in linkage disequilibrium (LD) decay in order to identify genomic regions that influence the phenotype using a GWAS approach. Key phenotypes included viremia and PCV2-specific antibodies at specific time points, overall viral load across the study, and growth rate as a measure of impact of infection. The proportion of phenotypic variation accounted for by SNP genotypes was limited early in the infection, but increased after the surge in viral replication and associated immune response. Specifically, SNP genotypes explained from 19% of phenotypic variation in PCV2 viremia at 7 days post infection (7 dpi) to 52% at 14 dpi (Table 1) . Similarly, SNP genotypes explained 14% and 3% of PCV2-specific IgM and IgG variation at 7 dpi, respectively, but this increased to 60% (IgM) and 44% (IgG) at 21 dpi. Overall, SNP genotypes explained 64% of the variation in viral load calculated across time points. In comparison, the contribution of SNP genotypes to variation in Average Daily Gain (ADG, monitoring growth rate through body weight) during the study period was limited, explaining 16% of the variation in overall ADG with 13% explained at 7 dpi and 7% at both 21 and 28 dpi.
The initial GWAS was performed using a BayesB-based approach where individual SNPs and successive 1 Mb windows of the genome were evaluated for association with phenotypic variation [7] . Bayesian regression models fit multiple SNPs in genome-wide associations, assuming that the marker effects result from a mixture of a point mass distribution whereby SNP have null effects and a distribution of non-zero effects (e.g., normal, heavy tailed). Prior assumptions are made relative to the genetic and environmental variances and the proportion of markers that have a null effect on a specific trait of interest. These models are implemented via a Markov chain Monte Carlo (MCMC) sampling algorithm. The posterior means are averaged over the number of samples from the MCMC [9] . Genome-wide average posterior distribution for the genetic variance was used to estimate the probability of each 1 Mb window having greater than the average genetic variance explained across PCV2-related traits (S1 Table) . The analysis identified two windows with greater than average window effect associated with both viral replication and immune response phenotypes (Pr > 0.90), assumed to represent Quantitative Trait Loci (QTL) (Fig 1) . One window associated with viral load was found on SSC7 in the vicinity of the swine leukocyte antigen complex class II (SLAII) at 24-25 Mb while the other was located near the proximal end of SSC12, at 3-4 Mb. The SNPs associated with the largest genetic variance, ALGA0039682 and ALGA0110477, in each of these two windows explained 65.1% and 99.7%, respectively of the genetic variance explained by their respective windows.
The SNP (ALGA0110477) associated with the largest effect on viral load explained 9.3% of the genetic variance and 6.2% of the phenotypic variance for PCV2 viral load (S1 Fig). This SNP was initially located on an unplaced scaffold in the previous 10.2 reference assembly. Estimating LD between ALGA0110477 and all other SNPs on the Porcine SNP60 BeadArray Variants in SYNGR2 influence PCV2 replication provided weak evidence of its location at the proximal end of the SSC12 reference sequence. Specifically, SNPs ALGA0122316, ASGA0089708, and ASGA0090188 had the highest LD estimates with ALGA0110477 (r 2 = 0.28-0.33). Interestingly, SNPs in the genomic region encompassing these markers did not show strong evidence of association with viral load despite LD with ALGA0110477. A more nuanced analysis fitting haplotypes across the region rather than individual SNPs using BayesIM [10] detected an effect in this genomic region (S2 Fig), without the inclusion of the previously unmapped ALGA0110477, providing support for the initial discovery based only on ALGA0110477. The unplaced scaffold containing the SSC12 marker, ALGA0110477, did not contain any annotated candidate genes that might underlie the observed effects, and the available sequence surrounding the marker only extended for 84 bp. Using inverse PCR (iPCR), the proximal sequence was extended to 1,252 bp. This extended sequence was used to interrogate contigs from an early version of a long read-based genome assembly of a pig (accession NPJO00000000), [11] which identified a 19 Mb scaffold that provided precise location and context for ALGA0110477 used for identification of candidates genes described below. The recent release of a long read-based improved reference assembly, https://doi.org/10.1371/journal.pgen.1007750.g001
Variants in SYNGR2 influence PCV2 replication Sscrofa 11.1 (GenBank accession GCA_000003025), supported more accurate ordering and placement of markers, including ALGA0110477 (SSC12, 3,673,576 bp). Profiling of the loci associated with PCV2-related phenotypes across time points following infection was performed in order to distinguish the role of host genetics in innate and adaptive immunity. One of the outputs of Bayesian analyses is model frequency, which provides the proportion of post-burn-in samplings that included a particular SNP covariate in the model. Model frequency can also be used to compare loci effects across multiple traits, despite differences in phenotypic and genetic variances. This analysis based on BayesIM supported the previous result, with the highest model frequency for viral load occurring within the previously identified locations on SSC7 and SSC12 (Fig 2) . In addition, haplotype effects estimated across the proximal end of SSC12 (0-10 Mb), provided evidence of haplotypes with divergent effects in viral load, with a peak detected at 3.7 Mb (S3 Fig). The two major QTLs were consistently observed for other targeted traits, including viremia (S4 Fig) . Both SSC7 and SSC12 QTLs had similar model frequencies at 14 dpi, while the QTL on SSC7 showed an increasing effect on viremia at 21 and 28 dpi. It should be noted that an additional QTL on the proximal end of SSC8 was detected for viremia at 14 dpi; this QTL had not been observed for viral load, and represented the largest effect for 14 dpi. The QTLs located on SSC7 and SSC12 were also observed for PCV2-specific antibody variation. Specifically, these QTLs were associated with IgM variation, indicative of active infection, starting at 14 dpi and with IgG variation, representing previous PCV2 exposure or vaccination, starting at 21 dpi (S5 and S6 Figs), supporting the hypothesis that they represent host variation affecting PCV2 infection including immune response. Variants in SYNGR2 influence PCV2 replication
SLAII role in PCV2 replication and immune response
One of the genomic regions associated with viral load was located on SSC7, in the vicinity of SLAII locus. The SNPs associated with the largest effects (ALGA0039682 and ALGA0039710, at 24.5 and 24.8 Mb, respectively) are located at the proximal end of SLAII with DRA being the closest gene (24.8 Mb) from the SLAII complex. Combined, these two SNPs explained 3.8% of the genetic variance for viral load. While the role of SLAII in antigen recognition and immune response in a variety of infectious diseases is well established, highly polymorphic genes and extended LD are the main factors limiting the discovery of functional variants. The SNP ALGA0039710, was still associated with the largest effect in viral load in an analysis of a subset of samples (n = 268) with extreme phenotypes that included novel SNPs located in genes in the QTL such as DRA, C2, CFB, NELFE, SKIV2L [12] .
Fine mapping and annotation of the QTL region located at the proximal end of SSC12
Previous to the recent release of the Sscrofa 11.1, we used the un-annotated long-read scaffold to identify the genes surrounding the SSC12 marker ALGA0110477. Ab initio gene prediction [13] and pBLAST combined with RNA-seq of peripheral blood were used for annotation of this QTL region. Thirteen potential genes with an e value > 7e -64 and a pBLAST score > 200
were identified. Five of these genes were found to be expressed in RNA-seq data of peripheral blood from pigs subjected to PCV2. These genes are involved in immune response and cytokine signaling (SOCS3), inhibition of apoptosis and promotion of cell proliferation (BIRC5), membrane trafficking and transport (SYNGR2) and transmembrane ion channels (TMC6 and Variants in SYNGR2 influence PCV2 replication TMC8). The number of isoforms observed across these genes varied from one (SOCS3) to more than 10 (TMC6). RNA-seq analysis of alternate ALGA0110477 homozygotes exhibiting extreme viral load following PCV2 challenge uncovered missense (n = 4), synonymous (n = 11), and UTR (n = 10) SNPs and an UTR indel across the 5 candidate genes located in the QTL region. In addition, 1-2 kb sequencing upstream of the Transcription Start Site (TSS) for BIRC5, SOCS3 and SYNGR2 uncovered 32 SNPs and 4 short indels. These novel polymorphisms and 580 SNPs from the Porcine SNP60 BeadArray were mapped to the 19 Mb scaffold using BLAT. The highest LD between ALGA0110477 and the polymorphisms mapped on the scaffold was with a SNP from the Porcine SNP60 BeadArray (ASGA0086395, r 2 = 0.55) located 24.5 kb away followed by a group of 3 SNPs from SYNGR2 (r 2 = 0.42-0.48) including the missense polymorphism SYNGR2 p.Arg63Cys located 123.7 kb away. Using an additive linear mixed model and a subset of pigs with extreme high and low viral loads (n = 268) genotyped for all polymorphisms mapped to the scaffold (n = 629), we found that the SYNGR2 p.Arg63Cys SNP and a 1bp indel located 343 bp upstream of BIRC5 TSS were associated with the largest effects on PCV2 viral load (Fig 3, F -ratio > 47, P < 0.0001). The phenotypic variance explained by each of these novel polymorphisms was substantially larger (21-23% +/-6.1-6.4%) compared to the original QTL SNP ALGA0110477 (12.6 +/-4.8%). As expected, these polymorphisms were associated with large effects on all weekly viremia measures (P < 0.0001), and on PCV2-specific antibodies, starting from 14 dpi for IgM and 21 dpi for IgG (p < 0.0001). The effects on growth during the challenge were most evident after 14 dpi as well as during the entire challenge period (0-28 dpi, P < 0.0005).
SYNGR2 a potential candidate gene influencing PCV2 replication
The SYNGR2 p.Arg63Cys SNP (SSC12, 3,797,516 bp) is located in the first loop of synaptogyrin-2 (SYNGR2) in a region conserved across mammals [14] known to be crucial for formation of microvesicle membrane fraction [15] . The Arg residue is prevalent in other species (e.g., human, rat, cow, horse) sometimes being replaced by His (Rhesus macaque, dog), Lys (prairie vole, Chinese hamster) or Gln (mouse, golden hamster) while the Cys residue appears to be specific to swine (Fig 4) . The substitution of Arg to Cys determines a change in charge and hydrophobicity of the loop (Fig 5) . The SYNGR2 p.63Cys allele is favorable with the viral load of the homozygous genotype (Least Square Mean = 54.3 units) being lower compared to the heterozygote (67.03 units, P = 0.005) and alternate homozygote (p.63Arg, 79.54 units, P < 0.0001). The favorable homozygous genotype was also associated with lower weekly viremia (P < 0.0001, Fig 6) , IgM (> 14 dpi, P < 0.0001, S7 Fig), IgG (> 21 dpi, P < 0.0001, S8 Fig) and higher growth (overall 0-28 dpi and > 14 dpi, P < 0.001) compared to the alternate homozygote. We hypothesize that the effects on growth and PCV2 specific antibodies are a result of the variation in viremia modulated by SYNGR2. Expression of SYNGR2 did not differ across SYNGR2 p.Arg63Cys genotypes or time points following in vivo PCV2 challenge. No interaction (P > 0.30) was detected between SYNGR2 p.Arg63Cys and the SNPs associated with the largest effects from the QTL detected on SSC7 (ALGA0039682 and ALGA0039710). The effect of this SNP was confirmed in an independent validation data set consisting of 71 pigs infected with the same PCV2b strain and representing all three SYNGR2 p.Arg63Cys genotypes. This SNP had an effect on viremia starting from 14 dpi to 42 dpi (P < 0.05). The viremia of the homozygous genotype for SYNGR2 p.63Cys allele was lower than the alternate homozygote (14-28 dpi, P < 0.05) and the heterozygote (14 dpi, P < 0.05).
Our inability to uncover the QTL located on SSC12 in our previous report [7] was based on 1) a genetic structure with a very limited number of homozygotes for SYNGR2 p.63Cys allele (Q = 1.2%) compared to Engle et al. (2014) dataset (Q = 18.3%), which is less favorable for detecting associations in additive statistical models, and 2) lower ability of the ALGA0110477 to capture the low viremic effects of SYNGR2 p.63Cys. While in the Engle et al. (2014) dataset the presence of the ALGA0110477 C variant had a probability of 65% to be located on the same haplotype with SYNGR2 p.63Cys, in McKnite et al. (2014) this variant is found in similar proportions in haplotypes that carry different SYNGR2 alleles (e.g. SYNGR2 p.63Cys; P = 55.9%).
The 1bp deletion located 343 bp upstream of the TSS of BIRC5 (BIRC5 g.-343delA) was found to be in high LD (r 2 = 0.83) with SYNGR2 p.63Cys allele and as expected was associated with low viral load (P < 0.0001). The deletion was predicted to affect a potential motif for NR5A2, a DNA-binding zinc finger transcription factor. However, no significant difference in expression was observed between BIRC5 genotypes across time points following in vivo PCV2 challenge (P < 0.17). At 14 dpi the homozygotes for the insertion exhibited an elevated nominal expression compared to the other genotypes, but the difference was not significant (P = 0.061 was present in the rest of the Western (Large White, Landrace, Hampshire and Berkshire) and indigenous Chinese breeds (Bamei, Jinhua, Meishan, Rongchang and Tibetan), as well as wild pigs such as common Warthog (Phacochoerus africanus), Java (Sus verrucosus) and Visayan (Sus cebifrons) warty pigs. Phylogenetic analysis based on the polymorphisms from this haplotype block separated the breeds into paternal (Pietrain, Duroc, Hampshire and Duroc) and indigenous Asian breeds while the maternal breeds (Large White and Landrace) were located in between these two groups (Fig 7) . Geographical location has an important role in the genetic relationships between indigenous Chinese breeds [16] . The breeds originating from the Tibetan plateau (Tibetan pigs from Sichuan region and Bamei pigs) share the same haplotype, which is similar with the haplotype of the pigs from the neighboring Rongchang region. In contrast, Meishan and Jinhua are from the middle-lower belt of Yangtze River and their haplotypes share more similarities. Variants in SYNGR2 influence PCV2 replication
The haplotype that carried the SYNGR2 p.63Cys allele (Hap1) was the closest to Pietrain and Duroc. The other haplotypes present in our resource population were similar to those identified in Berkshire (Hap 4), Hampshire (Hap 5), Meishan (Hap 2), or Jinhua (Hap 9). This finding suggests that SYNGR2 p.63Cys is the predominant allele in Duroc and Pietrain, breeds in which more emphasis is placed on growth related traits compared to breeds such as Large White and Yorkshire. Our analysis of SYNGR2 p.Arg63Cys in pure breeds showed that SYNGR2 p.63Cys has a frequency of 0.25 in Yorkshire, 0.53 in Landrace and 0.78 in Duroc.
Viral titer is decreased in SYNGR2-silenced cells infected with PCV2
Considering that the location of the SYNGR2 p.Arg63Cys substitution is in a conserved domain involved in vesicle formation [15] and recent literature support of SYNGR2 affecting replication of a tick-borne human RNA virus [17] , we hypothesized that SYNGR2 may play a role in the internalization and early release of PCV2 from endosomes influencing its replication. The Porcine kidney 15 cell line (PK15) has an epithelial origin and is a well-established model system for PCV2 innate immunity and cellular pathogenesis [2] . We found that PK15 cells carry both the SYNGR2 p.63Arg and the insertion of BIRC5 g.-343delA variants associated with high-viremia. Expression of SYNGR2 did not differ across time points following PCV2 Variants in SYNGR2 influence PCV2 replication infection of PK15 cells, corroborating in vivo findings. In order to validate a role of SYNGR2 in PCV2 replication, we transfected PK15 with siRNA targeting the mRNA of SYNGR2. We evaluated two siRNA (siRNA-01 and siRNA-03) at two different concentrations (10 nM and 20 nM) and found that siRNA-01 was the most efficient to knock-down mRNA level of SYNGR2 compared to the cells subjected to a scramble siRNA control. A substantial reduction (>75%) in SYNGR2 mRNA level was observed starting 24 hours after transfection (Fig 8) . PK15 cells with the expression of SYNGR2 silenced were then infected with PCV2 24 hours after transfection. A reduction in viral titer was observed in the SYNGR2 silenced cells subjected to PCV2b starting at 48 hours post infection (hpi) when compared to scramble siRNA and non-transfected control cells, indicating a role of SYNGR2 in viral replication (Fig 9) (P < 0.05) . The viral titer across time points was not statistically different between the scramble siRNA and non-transfected control cells (P > 0.54).
PCV2b titer is significantly lower in PK15 cells that carry an edited SYNGR2
PK15 edited clones were generated by CRISPR-Cas9 Ribonucleoprotein (RNP) complex approach with a pair of guide RNAs (31_AC/40_AC) targeting the second exon of SYNGR2 to cause a partial deletion of this exon and removal of the region containing the SYNGR2 p. Variants in SYNGR2 influence PCV2 replication Arg63Cys polymorphism (Fig 10) . Sequencing of the mRNA from selected PK15 edited clones revealed a single clone homozygous for the same 106 bp deletion (E1). This deletion is predicted to cause a shift in the reading frame and an altered protein (195 residues) beginning at amino acid residue 42 compared to the wildtype SYNGR2 sequence (224 residues). The deleted fragment included the conserved motif located in the first loop while the shift in the reading frame affected the C-terminus of SYNGR2. A significant reduction in viral titer starting at 24 hpi in cells (Fig 11) and 48 hpi in supernatant (Fig 12) was observed in the E1 edited clone compared to wildtype PK15 (P < 0.05).
The induced changes resulted in a potential nonsense-mediated mRNA decay, since a nominal reduction in expression of SYNGR2 was observed in E1 cells compared to wildtype PK15 cells with a significant difference observed at 24 hpi (P <0.05, S9 Fig) .
Discussion
Substantial variation in efficiency of viral replication and specific immune response was reported in our previous studies of experimental infections with PCV2 [7, 8] . Host genotype explained a substantial proportion of the phenotypic variation for viremia, viral load and immune response, with two major QTL identified on SSC7 and SSC12. Despite the presence of these two major loci, GWAS across time points following infection underlined the quantitative nature of the phenotypic variation of the targeted traits. The genetic complexity of PCV2 Variants in SYNGR2 influence PCV2 replication susceptibility has been augmented by the presence of a QTL in the vicinity of the SLAII complex of genes (SSC7). Despite the known role of this region in antigen recognition and immune response, high LD and genetic diversity have limited discovery of functional variants. Dissection of the SSC12 QTL based on gene annotation, genomic and RNA-sequencing uncovered a non-conservative substitution in a key domain of the SYNGR2 gene associated with PCV2 viremia and immune response. SYNGR2 is a non-neural member of the synaptogyrin family, a group of genes primarily expressed in the membrane of synaptic vesicles of neuronal cells with roles in vesicle biogenesis, exocytosis and recycling via endocytosis [15, 18] . There is limited information about the functional role of this member of the gene family. Recently, SYNGR2 was implicated as an active player in promoting viral RNA replication and immune evasion of severe fever with thrombocytopenia syndrome virus (SFTSV), a novel tickborne bunyavirus in humans [17] . SYNGR2 interacted with non-structural viral proteins to promote the formation of lipid-based inclusion bodies, which become virus factories within the cytoplasm of infected cells. SYNGR2 mRNA had been upregulated more than 200-fold at 36 hpi with SFTSV. In vitro silencing of SYNGR2 resulted in a decrease in viral replication and a reduction in the number and size of the inclusion bodies, further substantiating the role of SYNGR2 in facilitating SFTSV infection [17] .
Similarly, our study showed that silencing the expression of SYNGR2 in PK15 cells was associated with a significant reduction in PCV2 titer, indicating a role of SYNGR2 in promoting viral replication. SYNGR2 p.Arg63Cys, the only missense polymorphism identified in SYNGR2, is characterized by a predicted change in charge and hydrophobicity of the first loop that connects two essential transmembrane domains, and is located in a region conserved across mammals. In rats, the first intraluminal loop and the C-terminus of SYNGR2 were found to be crucial for successful incorporation of the protein into vesicular membranes and vesicle formation [15] . Replacement of residues 67-73 in the first loop led to protein degradation, with residues 70-73 having the largest impact [15] . In pigs, this segment of four residues is analogous to amino acids 60-63 and identical with the rat sequence (Val-Phe-Asn-Arg) corresponding to SYNGR2 p.63Arg allele (Fig 4) . Since the SYNGR2 p.Arg63Cys substitution is located within this crucial region, we hypothesize that SYNGR2 p.63Cys allele could influence incorporation of SYNGR2 into vesicular membranes, impact vesicle formation, and efficient trafficking of PCV2 to nucleus for replication. Using CRISPR-Cas9 that targeted the second exon which encodes this important motif, we generated a PK15 SYNGR2 edited clone. A reduction in viral titer observed in the edited clone, underlined the critical role of this gene in PCV2 susceptibility.
Predominance of the SYNGR2 p.63Cys allele in Pietrain and Duroc compared to other domestic and wild pig breeds could be a result of the subclinical effects that early PCV2 strains had on growth prior to the surge in PMWS in the early 1990's and the emphasis on growth in selection of these two breeds. In the Danish pig breeding program, five times more emphasis is placed on ADG (30-100 kg) in Duroc than in Large White or Landrace (Bolhom, 2010, personal communication; http://docplayer.net/20998319-Danish-pig-production.html). This selection pressure and the presence of mild PCV2 strains could have resulted in a rapid increase in the frequency of the SYNGR2 p.63Cys allele in both Pietrain and Duroc.
In our research we did not observe an increase in SYNGR2 mRNA levels following in vitro or in vivo infection with PCV2. This may reflect important distinctions between SFTSV and PCV2. For instance, SFTSV is an RNA virus with the capacity to replicate within intracytoplasmic inclusion bodies, or viral factories. As Sun et al. (2016) demonstrated, SYNGR2 is a component of these vesicles and necessary for their formation [17] . As SFTSV replicates, more viral factories will be required for viral proliferation, resulting in increased levels of SYNGR2. PCV2, on the other hand, is a DNA virus and can only replicate in the nucleus of host cells. Therefore, the potential role of SYNGR2 in PCV2 infection likely takes place prior to viral replication and may not require such an increase in SYNGR2 expression, but rather specific SYNGR2-PCV2 interactions. Since the position of this substitution is clearly located in a loop and not part of the transmembrane regions indicated by Janz and Sudhof (1998) and predicted by PSIPRED [19] (S10 and S11 Figs), an interaction between SYNGR2 and a ligand is favored compared to the potential impact of SYNGR2 p.Arg63Cys on overall protein folding or conformation of the first loop. A shift in the position of the second transmembrane helix as a result of the substitution in the loop region was predicted by HMMTOP software [20] , but not supported by others (e.g., TMHMM, DisEMBL, PSIPRED).
In this study, decreased viral titer by 1) exogenous reduction of SYNGR2 expression by siRNA along with 2) partial deletion of a key domain by gene editing, provided evidence of the involvement of SYNGR2 in PCV2 infection. Since the SYNGR2 p.Arg63Cys polymorphism is the only missense mutation within the entire gene and located in this key domain, it is a plausible QTN (Quantitative Trait Nucleotide) candidate for PCV2 susceptibility. However, future studies of the mechanistic role of SYNGR2 and specifically of SYNGR2 p.Arg63Cys substitution will be required to provide additional experimental evidence of their role in PCV2 replication and pathogenesis.
Materials and methods
Ethics statement
The experimental design and procedures used during this research project were approved by the Institutional Animal Care and Use Committee of the University of Nebraska -Lincoln.
Experimental design: Animals, diets, and housing
Experimental PCV2b challenge was conducted in nine batches that varied in size from 81 to 141 pigs, with a total of 974 pigs. The genetic makeup of this resource population consisted of crossbred pigs produced by 14 genetic lines generated by seven genetic programs. The dams of the experimental pigs had been vaccinated for PCV2 at 3 weeks of age with a single dose of Ingelvac CircoFLEX vaccine (Boehringer Ingelheim). The suppliers of the pigs also had vaccination programs for Porcine parvovirus, Erysipelothrix rhusiopathiae, Clostridium perfringens, Leptospirosis and Colibacillosis and tested negative for Porcine Reproductive and Respiratory Syndrome Virus (PRRSV). Prior to experimental infection, the pigs tested negative for presence of PCV2 in peripheral blood by real time quantitative PCR (qPCR) and had a sample/positive ratio (S/P) lower than 0.4 for IgM and 0.3 for passive IgG, the PCV2-specific antibodies [7] . Following infection, experimental pigs were examined daily for clinical signs of disease; weights and blood samples were collected at 0, 7, 14, 21 and 28 days post infection (dpi). Details of the experimental procedures, phenotypic and sample collection are described in Engle et al. (2014) and McKnite et al. (2014) .
A validation dataset consisting of a group of 71 pigs representing all three SYNGR2 p. Arg63Cys genotypes infected with the same PCV2b strain at 5 weeks of age was generated using the same experimental conditions. A group of 40 pigs (SYNGR2 p.63Arg/63Cys and 63Arg/63Arg) vaccinated for PCV2 at 3 weeks of age were used as controls. The vaccinated pigs were housed in the same room with the experimentally infected pigs, but in different pens.
PCV2b isolate and experimental infection
The PCV2b strain (UNL2014001) used for the experimental infection was obtained from a pig with symptoms characteristic to Post-weaning Multisystemic Wasting Syndrome (PMWS), which is the most common PCVAD syndrome. The strain was sequenced (accession KP016747.1) using dye terminators and the sequence was compared to PCV2 strains available in GenBank [8] . The strain was cultured in swine testicular cell lines as described [7] . At an average of 36 d all the pigs were inoculated with the UNL2014001 PCV2b strain with a titer of 10 4.0 50% tissue culture infection dose (TCID50) intranasally and intramuscularly.
Serologic profile: Quantification of viral DNA and PCV2-specific antibodies PCV2 specific antibodies, IgM and IgG, were profiled weekly from serum using ELISA (Ingenasa) as described in McKnite et al. (2014) . Estimates of the number of PCV2b copies, or viremia, was performed using viral genomic DNA isolated by QIAamp DNA Minikit (Qiagen) and quantified by qPCR using TaqMan Master Mix and ABI 7900 Real Time PCR System (Thermo Scientific). The viral load for each pig during the entire challenge was represented as area under the curve (AUC) based on an algorithm that takes into account viral levels observed at each time point following infection (0, 7, 14, 21, and 28 dpi) fitting a smooth curve over the 28 days and summing the areas in 0.01 time increments [21] .
Host genetic profile: DNA isolation, sequencing, polymorphism discovery and genotyping
The DNA was isolated from ear and tail tissue clips using DNeasy or Puregene blood and tissue kits (Qiagen). The experimental animals were genotyped using either the first or second generation of the Porcine SNP60 BeadArray (Illumina) that contain 62,183 and 61,565 SNPs, respectively. Only the common SNPs present in both BeadArray versions (91.6%, 61,177) were mapped on Sscrofa 11.1 porcine reference genome assembly and used in GWAS via GenSel software package [22] . DNA samples and SNP assays with a genotyping call rate below 80% were excluded from the analyses. A GenCall quality score of 0.40 was used as a minimum threshold for genotype quality [23] . Targeted DNA sequencing of candidate genes in the SSC12 QTL region including SOCS3, BIRC5 and SYNGR2 and their 2-4 kb region upstream of the transcription start sites (TSS) was performed using dye terminators and ABI PRISM 3100 Genetic Analyzer (Thermo Scientific) on high and low viremic samples. Discovery and validation of the polymorphisms detected by RNA-seq was based on alignment of DNA sequences using Sequencher software (Gene Codes). Potential impact of the polymorphisms located in the proximal promoter on important regulatory motifs was evaluated using FIMO (version 4.11.3) [24] and the JASPAR transcription profile database (version 2016).
Genotyping of polymorphisms located in the transcribed regions and proximal promoters of SOCS3, BIRC5, SYNGR2, THA1, TMC6 and TMC8 was performed by multiplex assays using Sequenom MassARRAY platform and Sequenom iPLEX chemistry based on the manufacturer protocols (Sequenom, San Diego, CA).
Genome-wide associations
The proportion of phenotypic variance explained by host genetics for PCV2-viremia, PCV2-specific antibodies (IgM and IgG) and average daily gain (ADGi) during experimental infection was estimated based on Porcine SNP60 BeadArray genotypes using a BayesB model [25] and GenSel software [22] . The statistical model included litter, pen and batch as class variables and passive IgG and age at infection as covariates. Bayesian analyses were based on π equal to 0.99 that assumed a prior probability of 1% of the SNPs having a non-zero effect. The Markov chain included 40,000 samples with the first 1,000 being removed as burn-in. Markov chain was set to use every 40 th sample to estimate posterior distribution for the genetic variance explained by each 1 Mb window of the reference genome. This distribution was used to estimate the probabilities of each 1Mb window having a variance greater than 0 or greater than the average variance explained by each 1Mb window as described in McKnite et al. (2014) . Bayes Interval Mapping (BayesIM) was implemented to derive haplotype effects across the genome on PCVAD-related traits as described in Kachman (2015) and Wilson-Wells and Kachman (2016) [11] . Briefly, a hidden Markov model was used to generate 8 haplotype states based on SNP genotypes [26] . Phenotypic variation of the targeted traits was analyzed with a hierarchical Bayesian model. QTL were placed every 50 kb across the genome while average haplotype size was set to 500 kb. Genetic variances, haplotype effects, and model frequencies were estimated at each locus. There were 42,000 MCMC samples collected with the first 2,000 used for burn-in. The model included batch, litter and pen as random effects and IgG and age at infection used as covariates. If a locus had an effect, haplotype effects for each cluster were modeled as independent normal random variables.
Associations between the single marker genotypes and phenotypic variation were tested using a linear mixed model fitted by JMP 10.0 (SAS Inst. Inc.) that included marker genotype and batch as fixed effects, litter and pen as random effects while age at infection and IgG were used as covariates. Additive and dominance effects were estimated for each of the targeted DNA polymorphisms. A similar model was used to estimate the interaction between SNPs. The potential effect on viral load of the haplotypes in the defined LD block from ALGA0110477 to SYNGR2 that includes 16 DNA polymorphisms, was estimated as haplotype substitution effects. Contrasts between haplotypes were estimated using a linear mixed model as described above including one variable for each haplotype with values 0, 1, and 2 corresponding to the animal having 0, 1, or 2 copies of the haplotype in question. The haplotype substitution effects were presented as deviations from the mean of the haplotypes.
Novel assembly and annotation of the proximal end of SSC12
Inverse PCR (iPCR), using four (AciI, AluI, HaeIII, HpaII, RsaII) and six cutter (EcoRI, HaeII, HincII, HindIII, KpnI, MfeI, MspA1l) restriction enzymes (New England Biolabs), T4 DNA ligase (New England Biolabs) and nested PCR using AmpliTaq Gold 360 DNA polymerase (Thermo Scientific), was employed to expand the genomic DNA sequence surrounding the short ALGA0110477 sequence, a SNP previously unmapped on the Sscrofa 10.2 reference genome. A genomic scaffold (19 Mb) of the proximal end of SSC12 was constructed based on Pacific Biosciences sequencing reads [11] . The position of the extended ALGA0110477 sequence and all SSC12 mapped and unmapped SNPs were determined on the genomic scaffold using BLAT. Annotation of the QTL region on the SSC12 scaffold was based on RNA-seq alignments and BLAST but also using ab initio approaches such as GenScan [13, 27] in combination with pBLAST.
RNA-seq and gene expression profiling
In order to profile transcriptome changes and sequence variation related to PCV2 infection, peripheral blood samples collected from the validation group of pigs that exhibited high (N TT = 6) and low (N CC = 5) viremic genotypes for ALGA0110477 at 0, 7 and 14 dpi were subjected to RNA sequencing. RNA was extracted from peripheral blood collected in Tempus tubes using the Tempus Spin RNA Isolation Reagent Kit (Thermo Scientific). RNA samples were sequenced using Ion Proton technology as described in the manufacturer protocol (Thermo Fisher Scientific Inc.). The adaptor-free sequencing reads were trimmed and filtered using Trim galore (version 0.4) [28] with low-quality bases in the 5' end being removed and nucleotides with quality call less than 22 being trimmed from the 3' end. The filtered reads were initially aligned to the SSC12 scaffold (19 Mb) using the two-step alignment approach used for Ion Proton transcriptome data that includes both Tophat and local-Bowtie [29] . The reads were later also aligned to the new pig assembly Sscrofa 11.1. The number of reads mapped to each gene in the annotated QTL region was obtained using HTSeq (version 0.6.1p1) [30] .
Expression of the candidate genes SOCS3, BIRC5 and SYNGR2 across time points following PCV2 infection was quantified using TaqMan Master Mix and CFX384 Real Time PCR (BioRad). The qPCR assays were designed using IDT Realtime PCR Tool software (www.idt. com) and sequences generated based on RNA-seq alignments. RNA was extracted from peripheral blood samples collected in Tempus tubes from a subset of pigs representing all genotypes from the validation data set that displayed extreme viral load (high vs low) (n = 40) from 0 to 21 dpi using the Tempus Spin RNA Isolation Reagent Kit (Thermo Scientific). Complementary DNA (cDNA) was obtained using a mix of random hexamers and poly dT primers using First strand cDNA Synthesis Kit (GE Healthcare Bio-Sciences). Expression of ribosomal protein L32 (Rpl32) gene was used for normalization. Mean normalized expression (MNE) values were calculated based on cycle crossing thresholds (CT) obtained for the technical triplicates taking qPCR efficiencies into account [31] . MNE values for ALGA0110477, SYNGR2 p. Arg63Cys or BIRC5 g.-343delA genotypes and time point following infection were log10 transformed and compared by t-test.
In vitro PCV2 infection of PK15 cells
The porcine kidney cell line (PK15) was grown in DMEM high glucose media supplemented with 10% FBS and 1% Penicillin-Streptomycin (5,000 U/mL). Cells were cultured in 12-well plates (4 cm ) when 80-100% confluent at MOI = 0.00025. One hour following infection, cells were washed and fresh media was added (DMEM high glucose and 2% FBS). The cells were incubated at 37˚C with 5% CO 2 for up to 5 days. Control cells were maintained the same way and mock-inoculated with plain DMEM high glucose media. Supernatants and cells were collected at specific time points and frozen at −80˚C. Viral DNA was extracted from supernatants using QIAamp DNA Mini kit (Qiagen). RNA, viral and host DNA was extracted from PK15 cells using AllPrep DNA/RNA Mini kit (Qiagen). TaqMan Master Mix and CFX384 Real Time PCR Detection System were used for quantification of PCV2 and expression profiling of BIRC5 and SYNGR2 from PK15 cells. Dideoxy sequencing of the cDNA and genomic DNA was used to profile the sequences and to genotype BIRC5 and SYNGR2 variants in PK15 cells. 
In vitro silencing of SYNGR2 in PK15 cells
In vitro editing of SYNGR2 in PK15 cells
Six potential guide RNAs targeting the second exon of SYNGR2 were designed and ordered (IDT), three located upstream (5') and three located downstream (3') of the SYNGR2 p. Arg63Cys polymorphism. Each guide RNA was hybridized with fluorescently labeled Alt-R CRISPR-Cas9 tracrRNA ATTO 550 (IDT) and Alt-R S.p. Hifi Cas9 Nuclease V3 (IDT) following the manufacturer's protocol to form Ribonucleoprotein (RNP) complexes. These RNP complexes were reverse transfected into PK15 cells using Lipofectamine RNAiMAX transfection reagent (Invitrogren) at a final concentration of 10nM. After 48 hours post transfection, genomic DNA was extracted using QIAamp Blood DNA Mini Kit (Qiagen) and amplified via PCR using LongAmp Taq DNA polymerase (NEB) with primers located in the introns flanking the second exon of SYNGR2 (5'-AGAAGGGAGAGACAGCACCA-3', 5'-CACCAGCA CATCTTCCACCT-3'). The amplicons were subjected to T7 endonuclease I (NEB) digestion following the manufacturer's protocol and visualized by agarose gel electrophoresis to assess cutting efficiency of each individual guide RNA. The ability of guide RNA pairs (upstream/ downstream) to generate partial deletions of the second exon was assessed following the same RNP transfection protocol with a final RNP concentration of 20nM (10nM/guide RNA). After 48 hours post transfection, genomic DNA was extracted, amplified, and visualized via agarose gel electrophoresis. A single guide RNA pair (sg31_AC/sg40_AC) was selected to generate PK15 edited clones. After 24 hours post transfection, the cells were collected and sorted using Fluorescence Activated Cell Sorting (FACS) into 96 well plates to generate single cell clones. Genomic DNA from each single cell clone was extracted using QuickExtract DNA extraction solution (Lucigen) following the manufacturer's protocol and genotyped by PCR amplification and gel electrophoresis. RNA was extracted from selected clones using All Prep DNA/RNA Mini kit (Qiagen) and PCR was performed with primers located in the 5' and 3' UTRs of the SYNGR2 mRNA sequence (5'-ACGGCGACAATGGAGAGCGG-3', 5'-GGGAAACAAGAGGGGC CAGCA-3') to amplify full-length transcripts, which were sequenced using Dideoxy sequencing. A single clone (E1) homozygous for a 106bp deletion was plated and infected with PCV2b inoculate as previously described. Wildtype PK15 cells were concurrently infected and served as a control.
To determine if induced changes in the mRNA sequence of SYNGR2 led to nonsense-mediated mRNA decay, expression of SYNGR2 was profiled by qPCR at 0, 24 and 48 hrs in edited and wildtype PK15 cells. 
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